The contractor shall provide preclinical development support for candidate products and drug development activities. The scope of work encompasses activities that range from initial product…
Active Awarded Last action
- Contract number
- 75N93021D00003
- Awardee
-
University Of North Carolina At Chapel Hill UEI D3LHU66KBLD5 Part of University Of North Carolina System Office
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 2 $16,911 obligated
Award facts
- Opportunity
-
- Preclinical Services for HIV Therapeutics Pre-Solicitation · 75N93019R00021 · Posted Oct 4, 2019
- Preclinical Services for HIV Therapeutics Solicitation · Posted Dec 5, 2019
- Combined order value
- $16,911 Current and potential, with all options
- Last date to order 87% complete
- IDV ceiling <1% used
- $107,274,471.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Allergy and Infectious Diseases awarded a multiple-award indefinite-delivery contract to University Of North Carolina At Chapel Hill for preclinical development support for HIV therapeutics with a ceiling of $107.3 million and an award date of October 15, 2020.
The contract covers preclinical services spanning initial product discovery through activities required to support clinical trials and product licensure. Work is performed in Chapel Hill, North Carolina. The scope encompasses seven task areas: in vitro testing, synthesis of therapeutic agents, small animal models for HIV/HBV/HCV and mycobacterium, formulation development and clinical dosage manufacturing, preclinical pharmacology and toxicology, and a reagent program for HIV and other infectious diseases. The originating solicitation anticipated 6–21 task orders annually, each valued at approximately $500,000 to $5 million.
The contract runs through October 14, 2027. No set-aside applies to the prime's award; however, the underlying solicitation reserved Task Area B (synthesis of therapeutic agents) under NAICS 541715 for small business concerns with a 1,000 employee size standard.
Two delivery orders have been issued under this IDIQ. The first, awarded June 1, 2021, valued at $16,910.91 and performed through September 30, 2021, required development of a quality assurance/quality control plan and participation in a task order initiation meeting in Chapel Hill, North Carolina. A second delivery order, awarded on the contract's base date of October 15, 2020 and completing June 3, 2021, funded the guaranteed minimum amount at $0 ceiling to support preclinical services for HIV therapeutics development in Chapel Hill.
Description
The contractor shall provide preclinical development support for candidate products and drug development activities. The scope of work encompasses activities that range from initial product discovery to those required to support clinical trials and/O
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N93021D00003?
75N93021D00003 was awarded to University Of North Carolina At Chapel Hill by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on October 15, 2020.
How much is contract 75N93021D00003 worth?
Orders under 75N93021D00003 have obligated $16,911. 75N93021D00003's own ceiling is $107,274,471.
How many orders have been placed under contract 75N93021D00003?
2 orders have been placed under 75N93021D00003, the latest on June 1, 2021.
Who can order from contract 75N93021D00003?
75N93021D00003 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75N93021D00003 part of a contract vehicle?
Yes. 75N93021D00003 is part of Preclinical Services for HIV Therapeutics.
Was contract 75N93021D00003 competed?
The extent of competition for 75N93021D00003 was full and open competition. The government received 3 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV